Science & Enterprise subscription

Follow us on Twitter

  • Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences li… https://t.co/WGboSsrf7U
    about 16 hours ago
  • New post on Science and Enterprise: Gene Therapy Company Exploring DNA Circuit Technology https://t.co/2YUM4DVZRK #Science #Business
    about 16 hours ago
  • A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects again… https://t.co/3JtSqD1Sa2
    about 20 hours ago
  • New post on Science and Enterprise: Vaccine Stops Lyme Bacteria in Preclinical Test https://t.co/7H0Lc90nRe #Science #Business
    about 20 hours ago
  • Stop the panic porn ... Coronavirus Variants Don’t Have to Be Scary. Still, Mask Up. https://t.co/d6aDu2Ucj6
    about 23 hours ago

Please share Science & Enterprise

Trial to Test Direct Crispr Blood Stem Cell Edits

Sickle cells illustration

A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits

Infographic – Covax Begins Vaccine Deliveries

Chart: Covax deliveries

Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries

Cell-Based Fish Company Gains $8.25M in Seed Funds

Bluu Bioscience founders

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Clinical Trial Tests In-Tumor Breast Cancer Therapy

Breast cancer self exam

A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled. . . . → Read More: Clinical Trial Tests In-Tumor Breast Cancer Therapy

Test Vaccine Protects Against Wide Coronavirus Range

Two piglets

Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range

Venture Fund to Support Seed-Stage Biotechs

KdT Ventures management

A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering. . . . → Read More: Venture Fund to Support Seed-Stage Biotechs

Precision Cancer Immunotherapy Biotech Underway

T-cells and cancer cells

A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds. . . . → Read More: Precision Cancer Immunotherapy Biotech Underway

Synthetic Antibodies Shown to Control Blood Glucose

DNAmolcule model

A company creating biologics derived from synthetic DNA and genes discovered antibodies that control blood glucose levels in lab animals. . . . → Read More: Synthetic Antibodies Shown to Control Blood Glucose

Joint Venture Developing Oral Covid-19 Vaccine

Capsules in a glass

Two biotechnology companies are forming a new enterprise to produce a vaccine as a capsule or tablet to protect against Covid-19 infections. . . . → Read More: Joint Venture Developing Oral Covid-19 Vaccine

Engineered Macrophage Cells Tested in Cancer Trial

Macrophage

A clinical trial is underway testing immune system cells called macrophages, with added cancer-killing proteins, as a treatment for solid tumor cancers. . . . → Read More: Engineered Macrophage Cells Tested in Cancer Trial